What is InjectSense?
InjectSense is at the forefront of developing ultra-miniature implantable sensors designed for continuous monitoring of critical physiological parameters such as pressure and oxygenation. Their innovative technology aims to provide physicians with vital health insights, ensuring data accessibility regardless of patient location. By merging expertise from the semiconductor and medical systems industries, InjectSense creates reliable, scalable devices that enhance therapy effectiveness through autonomous sensing. The company targets healthcare providers and patients, seeking to transform the standard of care with its advanced implantable solutions.
How much funding has InjectSense raised?
InjectSense has raised a total of $770K across 2 funding rounds:
Debt
$350K
Debt
$420K
Debt (2020): $350K with participation from PPP
Debt (2021): $420K led by PPP
Key Investors in InjectSense
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for InjectSense?
The recent major strategic investment positions InjectSense for significant scaling and further technological development. This enterprise-level backing suggests confidence in the company's trajectory and its potential to disrupt the digital health market. Future endeavors will likely focus on expanding product reach, enhancing sensor capabilities, and forging strategic partnerships within the healthcare ecosystem to accelerate adoption of their advanced implantable monitoring solutions.
See full InjectSense company page
